PATENT CLAIM ANALYSIS

Application Number: 15747292
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to identification of therapeutic agents for the treatment, diagnosis, and prevention of pulmonary hypertension.

Claim (Index 29):
The method of  claim 27 , wherein an inhibitor of ZIP12 activity or expression is administered to the subject.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 86.0
- Lexical Diversity: 1.10526
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13774695', '14352120', '13082203', '12823570', '12171661']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6879538576377056
- 35 USC 102 Novelty (BERT): 0.5310171106703138
- Combined Prediction Score: 0.6722601829409665
- Mean Citation Score: 203.596248
- Max Citation Score: 213.7278
- Similarity Product: 97.40595831563472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test